Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 12/2010

01.12.2010 | Neuro-ophthalmology

Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica

verfasst von: Masahiko Nakamura, Toru Nakazawa, Hiroshi Doi, Takehiro Hariya, Kazuko Omodaka, Tatsuro Misu, Toshiyuki Takahashi, Kazuo Fujihara, Kohji Nishida

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Neuromyelitis optica (NMO) is a recurring inflammatory neurological disease characterized by severe optic neuritis and myelitis. The purpose of this study was to determine whether the retinal nerve fiber layer thickness (RNFLT) is correlated with the clinical presentations in patients with NMO and to determine the clinical factors that lead to poor visual outcomes.

Methods

Thirty-five eyes of 18 patients with the NMO spectrum and 28 eyes of 14 patients with multiple sclerosis (MS) were studied. All of the patients had at least one episode of optic neuritis (ON) >6 months before being studied. The eyes were classified into four groups based on an episode of ON: NMO-ON, NMO eyes with at least one episode of ON; NMO-nonON, NMO eyes without an episode of ON; MS-ON, MS eyes with at least one episode of ON; and MS-nonON, MS eyes without an episode of ON. The RNFLT was measured by optical coherence tomography (OCT). The correlations between the RNFLT and the clinical data were determined.

Results

The overall RNFL was thinner in patients in the NMO-ON group than in the MS-ON group (63.84 µm vs. 84.28 µm; p = 0.0006) especially in the superior and inferior quadrants. The overall RNFLT was significantly correlated with the best-corrected visual acuity (BCVA) in both the NMO groups (r = 0.67; p < 0.0001) and the MS groups (r = 0.62; p = 0.0097). The overall RNFLT was negatively correlated with the number of relapses in the NMO group. A receiver operating characteristic (ROC) analysis showed that the cut-off value for a decrease in visual acuity to <20/20 was 71.41 µm of the overall RNFLT in the NMO group. The frequency of the ON relapses and the time for beginning the treatment with high-dose intravenous methylprednisolone (HIMP) significantly affected the preservation of the RNFLT.

Conclusions

The overall thinner RNFL in eyes with NMO than in eyes with MS indicates a greater loss of optic nerve axons in eyes with NMO. An early intervention with HIMP and preventing recurrences in NMO are critical for minimizing the axonal loss. Our findings indicate that OCT is an important method of evaluating loss of optic nerve axons in eyes with NMO and MS.
Literatur
1.
Zurück zum Zitat Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162–168CrossRefPubMed Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162–168CrossRefPubMed
2.
Zurück zum Zitat O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387CrossRefPubMed O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382–387CrossRefPubMed
3.
Zurück zum Zitat Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107–1114PubMed Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107–1114PubMed
4.
Zurück zum Zitat Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, Itoyama Y (2002) Pure optic-spinal form of multiple sclerosis in Japan. Brain 125:2460–2468CrossRefPubMed Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, Itoyama Y (2002) Pure optic-spinal form of multiple sclerosis in Japan. Brain 125:2460–2468CrossRefPubMed
5.
Zurück zum Zitat Fardet L, Genereau T, Mikaeloff Y, Fontaine B, Seilhean D, Cabane J (2003) Devic's neuromyelitis optica: study of nine cases. Acta Neurol Scand 108:193–200CrossRefPubMed Fardet L, Genereau T, Mikaeloff Y, Fontaine B, Seilhean D, Cabane J (2003) Devic's neuromyelitis optica: study of nine cases. Acta Neurol Scand 108:193–200CrossRefPubMed
6.
Zurück zum Zitat Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, Cabre P (2007) Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 114:810–815CrossRefPubMed Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, Cabre P (2007) Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 114:810–815CrossRefPubMed
7.
Zurück zum Zitat Papais-Alvarenga RM, Carellos SC, Alvarenga MP, Holander C, Bichara RP, Thuler LC (2008) Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol 126:12–16CrossRefPubMed Papais-Alvarenga RM, Carellos SC, Alvarenga MP, Holander C, Bichara RP, Thuler LC (2008) Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol 126:12–16CrossRefPubMed
8.
Zurück zum Zitat Weinshenker BG (2007) Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 64:899–901CrossRefPubMed Weinshenker BG (2007) Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 64:899–901CrossRefPubMed
9.
Zurück zum Zitat Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed
10.
Zurück zum Zitat Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477CrossRefPubMed Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477CrossRefPubMed
11.
Zurück zum Zitat Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489CrossRefPubMed
12.
Zurück zum Zitat Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130:1235–1243CrossRefPubMed Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y (2007) Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 130:1235–1243CrossRefPubMed
13.
Zurück zum Zitat Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450–1461CrossRefPubMed Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450–1461CrossRefPubMed
14.
Zurück zum Zitat Stadelmann C, Bruck W (2004) Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurol Sci 25(Suppl 4):S319–S322CrossRefPubMed Stadelmann C, Bruck W (2004) Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurol Sci 25(Suppl 4):S319–S322CrossRefPubMed
15.
Zurück zum Zitat Lucchinetti CF, Parisi J, Bruck W (2005) The pathology of multiple sclerosis. Neurol Clin 23:77–105, vi Lucchinetti CF, Parisi J, Bruck W (2005) The pathology of multiple sclerosis. Neurol Clin 23:77–105, vi
16.
Zurück zum Zitat Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, Itoyama Y (2006) Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 209:269–275CrossRefPubMed Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, Itoyama Y (2006) Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 209:269–275CrossRefPubMed
17.
Zurück zum Zitat Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194–1205CrossRefPubMed Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194–1205CrossRefPubMed
18.
Zurück zum Zitat Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254:1178–1181CrossRefPubMed Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254:1178–1181CrossRefPubMed
19.
Zurück zum Zitat Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, Cain CP, DiCarlo CD, Roach WP (1997) A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 115:1425–1428PubMed Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, Cain CP, DiCarlo CD, Roach WP (1997) A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 115:1425–1428PubMed
20.
Zurück zum Zitat Chen TC, Cense B, Miller JW, Rubin PA, Deschler DG, Gragoudas ES, de Boer JF (2006) Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol 141:1165–1168CrossRefPubMed Chen TC, Cense B, Miller JW, Rubin PA, Deschler DG, Gragoudas ES, de Boer JF (2006) Histologic correlation of in vivo optical coherence tomography images of the human retina. Am J Ophthalmol 141:1165–1168CrossRefPubMed
21.
Zurück zum Zitat Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58:383–391CrossRefPubMed Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58:383–391CrossRefPubMed
22.
Zurück zum Zitat Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freedman MS, Zackon DH, Kardon RH (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59:963–969CrossRefPubMed Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freedman MS, Zackon DH, Kardon RH (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59:963–969CrossRefPubMed
23.
Zurück zum Zitat Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113:324–332CrossRefPubMed Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113:324–332CrossRefPubMed
24.
Zurück zum Zitat Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31:286–293CrossRefPubMed Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 31:286–293CrossRefPubMed
25.
Zurück zum Zitat Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA (2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69:2085–2092CrossRefPubMed Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA (2007) Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 69:2085–2092CrossRefPubMed
26.
Zurück zum Zitat Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, Pablo L, Honrubia F (2008) Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 14:609–614CrossRefPubMed Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, Pablo L, Honrubia F (2008) Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 14:609–614CrossRefPubMed
27.
Zurück zum Zitat Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T, Balcer L (2006) Optical coherence tomography in multiple sclerosis. Lancet Neurol 5:853–863CrossRefPubMed Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T, Balcer L (2006) Optical coherence tomography in multiple sclerosis. Lancet Neurol 5:853–863CrossRefPubMed
28.
Zurück zum Zitat Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P (2008) Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 49:4412–4417CrossRefPubMed Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P (2008) Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci 49:4412–4417CrossRefPubMed
29.
Zurück zum Zitat Green AJ, Cree BA (2009) Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry 80:1002–1005CrossRefPubMed Green AJ, Cree BA (2009) Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry 80:1002–1005CrossRefPubMed
30.
Zurück zum Zitat Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72:1077–1082CrossRefPubMed Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72:1077–1082CrossRefPubMed
31.
Zurück zum Zitat Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y (2007) Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 13:128–132CrossRefPubMed Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y (2007) Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 13:128–132CrossRefPubMed
32.
Zurück zum Zitat Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, Itoyama Y (2007) Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 13:968–974CrossRefPubMed Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, Itoyama Y (2007) Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 13:968–974CrossRefPubMed
33.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127CrossRefPubMed McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127CrossRefPubMed
34.
Zurück zum Zitat de Seze J, Blanc F, Jeanjean L, Zephir H, Labauge P, Bouyon M, Ballonzoli L, Castelnovo G, Fleury M, Defoort S, Vermersch P, Speeg C (2008) Optical coherence tomography in neuromyelitis optica. Arch Neurol 65:920–923CrossRefPubMed de Seze J, Blanc F, Jeanjean L, Zephir H, Labauge P, Bouyon M, Ballonzoli L, Castelnovo G, Fleury M, Defoort S, Vermersch P, Speeg C (2008) Optical coherence tomography in neuromyelitis optica. Arch Neurol 65:920–923CrossRefPubMed
35.
Zurück zum Zitat Miyazawa I, Nakashima I, Petzold A, Fujihara K, Sato S, Itoyama Y (2007) High CSF neurofilament heavy chain levels in neuromyelitis optica. Neurology 68:865–867CrossRefPubMed Miyazawa I, Nakashima I, Petzold A, Fujihara K, Sato S, Itoyama Y (2007) High CSF neurofilament heavy chain levels in neuromyelitis optica. Neurology 68:865–867CrossRefPubMed
36.
Zurück zum Zitat Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group N Engl J Med 326:581–588 Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group N Engl J Med 326:581–588
37.
Zurück zum Zitat Beck RW, Cleary PA (1993) Optic neuritis treatment trial. One-year follow-up results Arch Ophthalmol 111:773–775 Beck RW, Cleary PA (1993) Optic neuritis treatment trial. One-year follow-up results Arch Ophthalmol 111:773–775
Metadaten
Titel
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica
verfasst von
Masahiko Nakamura
Toru Nakazawa
Hiroshi Doi
Takehiro Hariya
Kazuko Omodaka
Tatsuro Misu
Toshiyuki Takahashi
Kazuo Fujihara
Kohji Nishida
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 12/2010
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1344-7

Weitere Artikel der Ausgabe 12/2010

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2010 Zur Ausgabe

Editorial

Farewell

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.